Cure the Coronavirus Act This bill expands the tropical disease priority review voucher program to include COVID-19 (a respiratory disease caused by a novel coronavirus), thereby providing manufacturers with incentives for development of a vaccine.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Introduced in House
Referred to the House Committee on Energy and Commerce.
Health
Cardiovascular and respiratory healthDrug safety, medical device, and laboratory regulationEmergency medical services and trauma careInfectious and parasitic diseases
Cure the Coronavirus Act
USA116th CongressHR-6019| House
| Updated: 2/28/2020
Cure the Coronavirus Act This bill expands the tropical disease priority review voucher program to include COVID-19 (a respiratory disease caused by a novel coronavirus), thereby providing manufacturers with incentives for development of a vaccine.
Cardiovascular and respiratory healthDrug safety, medical device, and laboratory regulationEmergency medical services and trauma careInfectious and parasitic diseases